Cargando…

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance

Liver cirrhosis and hepatocellular carcinoma (HCC) are serious late complications that can occur after the Fontan procedure. This study aimed to investigate the cumulative incidence of cirrhosis and HCC and to identify specific features distinguishing HCC from benign arterial-phase hyperenhancing (A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Jun Sik, Lee, Dong Ho, Cho, Eun Ju, Song, Mi Kyoung, Choi, Young Hun, Kim, Gi Beom, Lee, Yun Bin, Lee, Jeong-Hoon, Yu, Su Jong, Kim, Haeryoung, Kim, Yoon Jun, Yoon, Jung-Hwan, Bae, Eun Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408507/ https://www.ncbi.nlm.nih.gov/pubmed/32640555 http://dx.doi.org/10.3390/cancers12071805

Ejemplares similares

Long-term Outcome of Fontan-Associated Protein-Losing Enteropathy: Treatment Modality and Predictive Factor of Mortality
por: Yoon, Ja-Kyoung, et al.
Publicado: (2022)

Adding MRI as a Surveillance Test for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Can Improve Prognosis
por: Yu, Su Jong, et al.
Publicado: (2023)

Successful Fontan Completion of a Single Ventricle with Floating Dysplastic Right Ventricle within the Left Ventricle
por: Hahn, Jong Woo, et al.
Publicado: (2021)

Hepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case report
por: Hur, Moon Haeng, et al.
Publicado: (2022)

Clinical Significance of Thrombosis in an Intracardiac Blind Pouch After a Fontan Operation
por: Lee, Sang Yun, et al.
Publicado: (2011)

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis
por: Cho, Eun Ju, et al.
Publicado: (2015)

Hepatocellular carcinoma after the Fontan procedure in a 16-year-old girl: A case report
por: Oh, Chaeyoun, et al.
Publicado: (2016)

The Outcome of Long QT Syndrome, a Korean Single Center Study
por: Ahn, Kyung Jin, et al.
Publicado: (2022)

Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study
por: Kim, Hyue Mee, et al.
Publicado: (2020)

Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis
por: Yu, Su Jong, et al.
Publicado: (2017)

Child-Pugh B or C Cirrhosis Increases the Risk for Bleeding Following Colonoscopic Polypectomy
por: Soh, Hosim, et al.
Publicado: (2020)

Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14
por: Cho, Yuri, et al.
Publicado: (2016)

Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation
por: Bae, Hyun-Mi, et al.
Publicado: (2011)

Prognostic Values of Inflammation-Based Scores and Fibrosis Markers in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Cho, Eun Ju, et al.
Publicado: (2022)

Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients
por: Nam, Joon Yeul, et al.
Publicado: (2017)

Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification
por: Lee, Minjong, et al.
Publicado: (2018)

Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway
por: Lee, Seulki, et al.
Publicado: (2020)

Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging
por: Hwang, Yoon Jung, et al.
Publicado: (2023)

Spontaneous Bacterial Peritonitis in Patients with Hepatitis B Virus-Related Liver Cirrhosis: Community-Acquired versus Nosocomial
por: Kim, Seung Up, et al.
Publicado: (2012)

End-of-Life Care of Hospitalized Children with Advanced Heart Disease
por: Lee, Joowon, et al.
Publicado: (2020)

Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
por: Jeon, Mi Young, et al.
Publicado: (2020)

Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis
por: Cha, Jung Hoon, et al.
Publicado: (2013)

CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
por: Chang, Young, et al.
Publicado: (2020)

Extracardiac Fontan with T-shape conduit in non-confluent pulmonary arteries
por: Kwak, Jae Gun, et al.
Publicado: (2008)

Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK
por: Lee, Seulki, et al.
Publicado: (2018)

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
por: Kim, Da Jung, et al.
Publicado: (2019)

Prognostic significance of viable tumor size measurement in hepatocellular carcinomas after preoperative locoregional treatment
por: Hwang, Yoon Jung, et al.
Publicado: (2021)

The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis
por: Chung, Goh-Eun, et al.
Publicado: (2021)

Case report: Adjuvant therapy with toceranib for an incompletely resected renal cell carcinoma with suspected pulmonary metastasis in a dog
por: Lee, Da-Eun, et al.
Publicado: (2023)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
por: Yu, Su Jong, et al.
Publicado: (2023)

Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Kim, Boram, et al.
Publicado: (2020)

Outcome of Initial Progression During Nivolumab Treatment for Hepatocellular Carcinoma: Should We Use iRECIST?
por: Lee, Dong Ho, et al.
Publicado: (2021)

Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
por: Yoon, Jun Sik, et al.
Publicado: (2019)

Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study
por: Kim, Hwi Young, et al.
Publicado: (2018)

Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B
por: Yoo, Jeong-Ju, et al.
Publicado: (2020)

Lidocaine intensifies the anti-osteogenic effect on inflammation-induced human dental pulp stem cells via mitogen-activated protein kinase inhibition
por: Lee, Sang-Hoon, et al.
Publicado: (2023)

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
por: Cho, Yuri, et al.
Publicado: (2015)

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
por: Lee, Cheol-Hyung, et al.
Publicado: (2020)

Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma
por: Yu, Su Jong, et al.
Publicado: (2010)

Idiopathic midaortic syndrome with malignant hypertension in 3-year-old boy
por: Ahn, Kyung Jin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ib52esqbh7g2fcd5f0ha17tld0